TiO2 Still A California Prop 65 Target; EU Commission Returns To SCCS With New Safety Questions
Executive Summary
Titanium dioxide use in cosmetic products is getting another look by the EU’s Scientific Committee on Consumer Safety, with a focus on genotoxicity and exposure via inhalation and oral routes. Stateside, potentially respirable TiO2 continues to be the focus of Prop 65 lawsuits in California.
You may also be interested in...
US Ninth Circuit On Glyphosate Prop 65 Listing Could Have Big Implications For TiO2 And Beyond
Industry complaints about California’s Prop 65 program are nothing new, but First Amendment cases against the state’s attorney general currently moving through California federal courts could have novel, outsized impacts. The Personal Care Products Council, which is suing over a titanium dioxide listing, awaits a review of glyphosate litigation pending in the Ninth Circuit.
EU Court Shoots Down TiO2 Hazard Classification, Opening Door For Future Challenges
Titanium dioxide stakeholders argued successfully in the Court of Justice of the European Union that TiO2’s hazard classification in 2020 under the CLP was based on shoddy science and a flawed interpretation of EU law. The industry win comes as the European Commission is finalizing a regulation to establish new CLP hazard classes, including for endocrine disruptors.
EU Reg Consultant On CLP Revisions: Take A Breath, Cost It Out, Consider ‘Lobbying And Pushing Back’
Louise Witter of UK-based Chemical Legislation Professionals spoke with HBW Insight ahead of the European Commission’s 19 December adoption of a proposal to revise the CLP by introducing new hazard classes, including for endocrine disruptors.